Posted on November 30, 2021 by Scott Shuda
Medical laser company, Iridex (IRIX), CEO David Bruce is interviewed on the company’s proprietary laster treatments for glaucoma.
Iridex is unique in having treatment options across the entire spectrum of glaucoma progression:
More, Iridex’ full-suite of treatment options provides an alternative to a lifetime of expensive drops or invasive surgery.
Disclosure: I am long Iridex and might buy or sell shares at any time.